Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy.
Trivedi MS, Arber N, Friedman E, Garber JE, Holcomb K, Horowitz NS, Wright JD, Lee JJ, Vornik LA, Abutaseh S, Castile T, Sauter ER, Dimond E, Heckman-Stoddard BM, House M, Samimi G, Brown PH, Crew KD.
Trivedi MS, et al. Among authors: sauter er.
Cancer Prev Res (Phila). 2022 Nov 1;15(11):721-726. doi: 10.1158/1940-6207.CAPR-22-0051.
Cancer Prev Res (Phila). 2022.
PMID: 36001346
Free PMC article.